Pancreatitis Cases Linked to Weight Loss Jabs in Ireland
Reports of pancreatitis are being investigated in connection to popular weight loss medications.
Ireland’s medicines watchdog, the Health Products Regulatory Authority (HPRA), has confirmed multiple reports linking pancreatitis to the use of weight loss injections.
GLP-1 Drugs Under Review
Drugs containing GLP-1 receptor agonists, such as Ozempic and Mounjaro, are currently under review in the UK. This review follows a notable increase in reported adverse reactions associated with these medications. More information can be found on the MHRA website.
What is Pancreatitis?
Pancreatitis is an inflammation of the pancreas. Symptoms can include severe abdominal pain, nausea, and vomiting. If you experience these symptoms while taking weight loss medications, seek immediate medical attention.
Regulatory Actions and Future Investigations
The HPRA is actively investigating the reports and collaborating with international regulatory agencies to assess the potential risks associated with these medications. Further updates will be provided as the review progresses.
Important Information
Consult with your doctor before starting any new medication, especially if you have a history of pancreatitis or other medical conditions.
Learn More
